News from breckenridge pharmaceutical, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 19, 2014, 14:35 ET

Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd.

Breckenridge Pharmaceutical, Inc. announced today that it has entered into a multi-product agreement with MSN Laboratories Pvt. Ltd. (Hyderabad,...

Nov 25, 2014, 15:30 ET

Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc.

 Breckenridge Pharmaceutical, Inc. announced today that it has entered into a multi-product ANDA agreement with Pii (Pharmaceutics...

Nov 20, 2014, 10:00 ET

Breckenridge Announces Appointment of New President

 Breckenridge Pharmaceutical, Inc. announced the appointment of Larry Lapila to the position of President. Lapila previously served as...

Nov 03, 2014, 10:00 ET

Breckenridge Announces Approval of QUETIAPINE FUMARATE TABLETS

 Breckenridge Pharmaceutical, Inc. announces the approval of Quetiapine Fumarate Tablets.  Quetiapine Fumarate Tablets are AB rated to...

Oct 14, 2014, 10:00 ET

Breckenridge Pharmaceutical, Inc. Announces Approval of Mefenamic Acid Capsules, USP 250mg

Breckenridge Pharmaceutical, Inc. announces the immediate launch of Mefenamic Acid 250mg Capsules.  The U.S. Food and Drug Administration...

Sep 05, 2014, 12:00 ET

Breckenridge Pharmaceutical, Inc. Announces Paragraph IV ANDA Litigation with Novartis AG for its ANDA Everolimus Oral Tablets (Zortress®)

Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for Everolimus oral tablets, 0.25 mg,...

Jun 23, 2014, 13:00 ET

Breckenridge Pharmaceutical, Inc. Announces Paragraph IV ANDA Litigation with Cephalon, Inc. for its ANDA Bendamustine HCl Powder for IV (Treanda®)

 Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for bendamustine hydrochloride...

Sep 11, 2013, 17:13 ET

Breckenridge Completes Acquisition of Certain Cypress Products from Pernix Therapeutics

 Breckenridge Pharmaceutical, Inc. announced today that it has completed its acquisition of certain Cypress Pharmaceutical, Inc. product assets...

Aug 09, 2013, 08:17 ET

Breckenridge Enters Into Agreement to Acquire Certain Cypress Assets from Pernix Therapeutics

 Breckenridge Pharmaceutical, Inc. announced today that it has entered into an agreement to acquire from Pernix Therapeutics, certain assets...

Jul 09, 2013, 14:52 ET

Breckenridge Announces Dismissal of Various Lawsuits Against Macoven Pharmaceuticals in Return for Macoven's Discontinuance of Certain Products

 Breckenridge Pharmaceutical, Inc. announced today that Nestle Health Science-Pamlab and Merck & Cie have dismissed their patent litigation...

Jul 03, 2013, 10:31 ET

Breckenridge Announces Approval of Rizatriptan Benzoate ODT (Orally Disintegrating Tablets)

 Breckenridge Pharmaceutical, Inc. announces the immediate launch of Rizatriptan Benzoate Orally Disintegrating Tablets.  The U.S. Food...

Jun 28, 2013, 11:47 ET

Breckenridge Announces Paragraph IV ANDA Litigation with Par Pharmaceutical & Alkermes Pharma Ireland Limited for its ANDA Megestrol Acetate Oral Suspension (Megace® ES)

Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for Megestrol Acetate Oral...

Mar 26, 2013, 12:33 ET

Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules

 Breckenridge Pharmaceutical, Inc. announced today that it has entered into an agreement with Aptalis Pharmatech, Inc. to market Propranolol...

Feb 13, 2013, 15:10 ET

Breckenridge Announces Approval for Pioglitazone Hydrochloride tablets

 Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug...

Dec 30, 2012, 10:00 ET

Breckenridge Announces Approval of Rizatriptan Benzoate Tablets

 Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Rizatriptan Benzoate Tablets.  The U.S. Food and Drug...

Dec 18, 2012, 16:51 ET

Breckenridge Announces Approval for Lansoprazole Delayed-Release Rx Capsules

 Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Prescription Lansoprazole Delayed-Release Capsules.  The U.S....

Oct 12, 2012, 15:02 ET

Breckenridge announces agreement with Marksans Pharma, Ltd. to market Gabapentin Capsules

 Breckenridge Pharmaceutical, Inc. announced today that it has entered into an agreement with Marksans Pharma, Ltd to market its Abbreviated...

Oct 03, 2012, 15:13 ET

Breckenridge announces agreement with Ajanta Pharma, Ltd. to market Risperidone Tablets

 Breckenridge Pharmaceutical, Inc. announced today that it has entered into an agreement with Ajanta Pharma, Ltd. to market its Abbreviated New...

Jun 27, 2012, 20:17 ET

Breckenridge and Alembic Announce Paragraph IV ANDA Litigation with Pfizer on Desvenlafaxine tablets (Pristiq®)

 Breckenridge Pharmaceutical, Inc. announced today that Breckenridge and Alembic Pharmaceuticals Limited were named codefendants in a Paragraph...

Jun 14, 2012, 14:47 ET

Breckenridge and Alembic Announce Settlement with Novartis of PIV litigation on Rivastigmine Tartrate Capsules

BOCA RATON, Fla., June 14, 2012 /PRNewswire/ --  Breckenridge Pharmaceutical, Inc. announced today that Breckenridge and Alembic...